ER+/HER2+ Metastatic Breast Cancer
2 Bekeken
• 07/03/23
0
0
insluiten
administrator
abonnees
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties